A randomized controlled trial of prophylactic isolated cytotoxic perfusion for poor-prognosis primary melanoma of the lower limb
- 28 February 1997
- journal article
- clinical trial
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 23 (1) , 6-9
- https://doi.org/10.1016/s0748-7983(97)80134-5
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Regional therapy of melanomaEuropean Journal Of Cancer, 1993
- High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma.Journal of Clinical Oncology, 1992
- Isolated Limb Perfusion for Localized Melanoma of the ExtremityArchives of Surgery, 1990
- The role of regional hyperthermic cytostatic perfusion in the treatment of extremity melanomaCancer, 1988
- Comparison of two methods of treating primary malignant melanomas clark IV and V, thickness 1.5 mm and greater, localized on the extremities. Wide surgical excision with and without adjuvant regional perfusionCancer, 1986
- Hyperthermic adjuvant perfusion chemotherapy for stage I malignant melanoma of the extremity with literature reviewCancer, 1983
- Prophylactic Isolation-perfusion as the Primary Therapy for Invasive Malignant Melanoma of the LimbsAnnals of Surgery, 1975
- Asymptotically Efficient Rank Invariant Test ProceduresJournal of the Royal Statistical Society. Series A (General), 1972
- Chemotherapy of CancerAnnals of Surgery, 1958
- FRACTIONATED INTRA-ARTERIAL CANCER. CHEMOTHERAPY WITH METHYL BIS AMINE HYDROCHLORIDE; A PRELIMINARY REPORTAnnals of Surgery, 1950